Advertisement.

NRIFF Projected Dividend Yield

Nuvo Pharmaceuticals Inc ( OTCBB : NRIFF )

Nuvo Pharmaceuticals develops products internally to enter into strategic alliances or licensing agreements with national or international pharmaceutical companies that have the necessary resources and distribution networks to market and sell its pharmaceutical products. Co.'s primary research and development (R&D) is directed towards pain drug products that are delivered into and through the skin. Co. is also involved in R&D activities involving WF10, a chlorite based immunomodulating drug, through its 60% ownership in Nuvo Research AG. Co. manages these activities as two business and research segments: Pain and Immunology.

20 YEAR PERFORMANCE RESULTS

NRIFF Dividend History Detail
NRIFF Dividend News
NRIFF Competitors News

# of Shares: 0

Closing Price: 0.75

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend Amount (CAD)
Total:					0.0000